Alloimmunization in patients with sickle cell disease in French Guiana.
This study in French Guiana assessed the frequency of alloimmunization to red cell antigens in sickle cell disease patients over 1995-2011 and identified the most common antibodies. A retrospective analysis of the transfusion history and medical records of 302 patients showed that 29/178 transfused patients had developed alloantibodies (16%). The most frequent alloantibodies were anti-LE1, anti-MNS1, anti-LE2, and anti-FY1 and were developed after transfusion of standard red cell units. The frequency of the clinically significant antibodies in this population of SCD patients was 11% (19/178). The antibodies found on those patients who had delayed hemolytic transfusion reaction were anti-K1, anti-FY1, and anti-MNS3. The strategies used to decrease alloimmunization in French Guiana are discussed.
Pediatric Unit, Cayenne Hospital, rue des Flamboyants, BP 6006, 97306 Cayenne Cedex, French Guiana.
Narcisse
N
Elenga
French Guianese Blood Agency, Cayenne Hospital, rue des Flamboyants, BP 6006, 97306 Cayenne Cedex, French Guiana.
Loic
L
Niel